Global Uterine Fibroids Treatment Devices Market – Insights
Uterine fibroids are benign tumors that originate in the uterus (womb). The condition may leads to pelvic pain, excessive menstrual bleeding, and frequent urination. The condition is more prevalent in women that often have a family history of fibroids. Minimal invasive surgical treatments and surgeries such as hysterectomy, cryosurgery, myomectomy, uterine artery embolization, and MRI-guided high-intensity focused ultrasound are available for the treatment of uterine fibroids.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/2047
Global Uterine Fibroids Treatment Devices Market: Drivers
High prevalence of uterine fibroids is expected to boost growth of the global uterine fibroids treatment devices market over the forecast period. For instance, according to the National Health Service, the U.K. recorded 30,929 cases of uterine fibroid in the year 2012 – 2013. Moreover, increasing number of hysterectomies performed worldwide is also expected to aid in growth of the market. For instance, according to National Uterine Fibroids Foundation, in 2010, an estimated 12 hysterectomies were performed in the U.S. every 10 minutes and around 600,000 hysterectomies were performed annually in the U.S. out of which around 170,000 – 300,000 were performed due to uterine fibroids.
High incidence of uterine cancer is expected to fuel growth of the global uterine fibroids treatment devices market over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), around 53,028 women were diagnosed with uterine cancer in the U.S. in 2014.
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2047
Global Uterine Fibroids Treatment Devices Market: Regional Analysis
North America is expected to hold dominant position in the global uterine fibroids treatment devices market over the forecast period. This is attributed to high incidence of uterine cancer in the region. For instance, according to the CDC, uterine cancer led to around 9,727 deaths of women in the U.S. in 2014.
Increasing launch of novel therapies for the treatment of uterine fibroids is expected to propel growth of the market in Europe. For instance, in January 2018, Hologic received CE Mark for its minimally invasive hysteroscopic treatment option, MyoSure system.
Global Uterine Fibroids Treatment Devices Market: Competitive Landscape
Major players operating in global uterine fibroids treatment devices market include Advanced Surgical Concepts, PLLC, Boston Scientific Corporation, CONMED Corporation, CooperSurgical, Inc., Ethicon, Inc., Hologic, Inc., Medtronic, Plc, Olympus Corporation, PENTAX Medical, and Stryker Corporation.
To get detailed table of content (ToC), please click: https://www.coherentmarketinsights.com/ongoing-insight/toc/2047
Global Uterine Fibroids Treatment Devices Market: Key Developments
Major players in the market are focused on product approval and launch to expand their product portfolio. For instance, in 2015, SonaCare Medical received U.S. FDA approval for its Sonablate 450 – a device indicated for trans-rectal High Intensity Focused Ultrasound (HIFU) ablation of prostatic tissue.
Global Uterine Fibroid Treatment Devices Market Taxonomy
By Technology Type
- Surgical techniques
- Laparoscopic techniques
- Laparoscopic Myomectomy
- Ablation Techniques
- Microwave Ablation
- Ultrasound Ablation
- High Intensity Focused Ultrasound (HIFU)
- MRI-guided Focused Ultrasound (MRgFUS)
- Other Ablation Techniques
- Embolization Techniques
By Mode of Treatment
- Invasive Treatment
- Minimally Invasive Treatment
- Non-Invasive Treatment
By End User
- Ambulatory Surgical Center
- North America
- Asia Pacific
- Latin America
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027